Industry News
Worrying Decline In Mammograms After Task Force Recommendation
Jun 28, 2012
Preventive mammography rates in women in their 40s have dropped nearly 6 percent nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, a Mayo Clinic analysis shows. That represents a small but significant decrease since the controversial guidelines were released, the researchers say... Read More
Researchers Test Drug Combinations To Prevent Graft Vs. Host Disease
Jun 28, 2012
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT)... Read More
Researchers Test Drug Combinations To Prevent Graft Vs. Host Disease
Jun 28, 2012
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT)... Read More
Elekta's Agility Radiation Therapy Beam-Shaping Innovation For Cancer Treatments Receives U.S. 510(k) Clearance
Jun 28, 2012
Utilizing new and faster technology, Agility multi-leaf collimator (MLC) expected to further improve therapy for oncology patients, accelerate treatment times Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta's revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy t... Read More
Elekta's Agility Radiation Therapy Beam-Shaping Innovation For Cancer Treatments Receives U.S. 510(k) Clearance
Jun 28, 2012
Utilizing new and faster technology, Agility multi-leaf collimator (MLC) expected to further improve therapy for oncology patients, accelerate treatment times Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta's revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy t... Read More
Glucose Deprivation Activates Feedback Loop That Kills Cancer Cells
Jun 28, 2012
Compared to normal cells, cancer cells have a prodigious appetite for glucose, the result of a shift in cell metabolism known as aerobic glycolysis or the "Warburg effect." Researchers focusing on this effect as a possible target for cancer therapies have examined how biochemical signals present in cancer cells regulate the altered metabolic state... Read More
Glucose Deprivation Activates Feedback Loop That Kills Cancer Cells
Jun 28, 2012
Compared to normal cells, cancer cells have a prodigious appetite for glucose, the result of a shift in cell metabolism known as aerobic glycolysis or the "Warburg effect." Researchers focusing on this effect as a possible target for cancer therapies have examined how biochemical signals present in cancer cells regulate the altered metabolic state... Read More
Metformin Shows Promise For Pancreatic Cancer Patients
Jun 27, 2012
According to the results of some preclinical trials, low doses of metformin, an antidiabetic drug, may effectively eliminate cancer stem cells, a group of cells believed to be responsible for tumor initiation, as well as tumor relapse, given that these cells are resistant to standard chemotherapies... Read More
Metformin Shows Promise For Pancreatic Cancer Patients
Jun 27, 2012
According to the results of some preclinical trials, low doses of metformin, an antidiabetic drug, may effectively eliminate cancer stem cells, a group of cells believed to be responsible for tumor initiation, as well as tumor relapse, given that these cells are resistant to standard chemotherapies... Read More
Study Of Lung Cancer Death Rates Among Young And Middle-Aged White Women; Tobacco Control Implicated In Rise
Jun 27, 2012
A new study comparing lung cancer death rates among women by year of birth shows dramatic differences in trends between states, likely reflecting the success or failure of tobacco control efforts... Read More
Previous Page Next Page